US Bancorp’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38K Sell
402
-311
-44% -$5.43K ﹤0.01% 3503
2025
Q4
$12.7K Sell
713
-637
-47% -$11.2K ﹤0.01% 3251
2025
Q3
$25K Sell
1,350
-229
-15% -$4.72K ﹤0.01% 2980
2025
Q2
$33.9K Sell
1,579
-743
-32% -$16.1K ﹤0.01% 2961
2025
Q1
$57.2K Buy
2,322
+13
+0.6% +$321 ﹤0.01% 2686
2024
Q4
$53.5K Sell
2,309
-412
-15% -$10.3K ﹤0.01% 2708
2024
Q3
$73.8K Sell
2,721
-379
-12% -$11.5K ﹤0.01% 2545
2024
Q2
$89.2K Sell
3,100
-145
-4% -$4.45K ﹤0.01% 2393
2024
Q1
$94.6K Sell
3,245
-1,189
-27% -$33.2K ﹤0.01% 2395
2023
Q4
$144K Sell
4,434
-1,694
-28% -$49.1K ﹤0.01% 2177
2023
Q3
$196K Sell
6,128
-49
-0.8% -$1.89K ﹤0.01% 1838
2023
Q2
$271K Sell
6,177
-335
-5% -$15.4K ﹤0.01% 1721
2023
Q1
$288K Buy
6,512
+132
+2% +$5.83K ﹤0.01% 1694
2022
Q4
$253K Sell
6,380
-533
-8% -$22.2K ﹤0.01% 1732
2022
Q3
$320K Sell
6,913
-289
-4% -$14.2K ﹤0.01% 1602
2022
Q2
$311K Sell
7,202
-386
-5% -$17.7K ﹤0.01% 1678
2022
Q1
$411K Sell
7,588
-1,212
-14% -$61.9K ﹤0.01% 1620
2021
Q4
$527K Sell
8,800
-594
-6% -$37K ﹤0.01% 1500
2021
Q3
$615K Sell
9,394
-213
-2% -$13.8K ﹤0.01% 1422
2021
Q2
$607K Sell
9,607
-437
-4% -$25.1K ﹤0.01% 1447
2021
Q1
$489K Sell
10,044
-39
-0.4% -$1.87K ﹤0.01% 1512
2020
Q4
$416K Sell
10,083
-1,044
-9% -$47.9K ﹤0.01% 1539
2020
Q3
$510K Buy
11,127
+936
+9% +$43.4K ﹤0.01% 1322
2020
Q2
$447K Sell
10,191
-886
-8% -$39.8K ﹤0.01% 1356
2020
Q1
$438K Buy
11,077
+2,062
+23% +$92.4K ﹤0.01% 1271
2019
Q4
$423K Buy
9,015
+2,771
+44% +$107K ﹤0.01% 1456
2019
Q3
$221K Buy
6,244
+1,937
+45% +$67.1K ﹤0.01% 1755
2019
Q2
$168K Buy
4,307
+375
+10% +$15.1K ﹤0.01% 1917
2019
Q1
$173K Buy
3,932
+20
+0.5% +$761 ﹤0.01% 1890
2018
Q4
$137K Buy
+3,912
New +$124K ﹤0.01% 1952

Other funds holding KIDS

US Bancorp's KIDS Position: Q1 2026 in Review

US Bancorp reduced its OrthoPediatrics (KIDS) stake by 44% in Q1 2026, selling an estimated $5.43K and leaving 402 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

US Bancorp first reported a position in KIDS in Q4 2018 and has held it in 30 quarters since. The position peaked at $615K in Q3 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • US Bancorp held 402 shares of OrthoPediatrics worth $6.38K as of Q1 2026.
  • US Bancorp sold 311 OrthoPediatrics shares in Q1 2026, an estimated $5.43K.
  • OrthoPediatrics made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3503 holding.
  • US Bancorp first reported a position in OrthoPediatrics in Q4 2018 and has held it in 30 quarters since.
  • US Bancorp's OrthoPediatrics position peaked at $615K in Q3 2021.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.